Published on in Vol 7, No 8 (2018): August

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Nikhil Chauhan   1 , PhD ;   Janet Bukovcan   1 , BSc (Hons) ;   Eveline Boucher   1 , MD ;   David Cosgrove   2 , MD ;   Julien Edeline   3 , MD, PhD ;   Bonnie Hamilton   1 , BSc ;   Laura Kulik   4 , MD ;   Fayaz Master   1 , BSc ;   Riad Salem   5, 6, 7 , MBA, MD

1 Research and Development, BTG International group companies, London, United Kingdom

2 Division of Medical Oncology, Vancouver Cancer Center, Compass Oncology, Vancouver, WA, United States

3 Department of Oncology, Centre Eugene Marquis, Rennes, France

4 Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern Memorial Hospital, Chicago, IL, United States

5 Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, IL, United States

6 Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, IL, United States

7 Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, IL, United States

Corresponding Author: